Veradermics, Incorporated
MANE
$126.89
$7.526.30%
NYSE
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 8.94M | 4.82M | 1.47M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 29.86M | 23.01M | 12.92M | ||
| Operating Income | -29.86M | -23.01M | -12.92M | ||
| Income Before Tax | -27.23M | -21.85M | -12.40M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -27.23M | -21.85M | -12.40M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -27.23M | -21.85M | -12.40M | ||
| EBIT | -29.86M | -23.01M | -12.92M | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | -1.32 | -37.62 | -19.79 | ||
| Normalized Basic EPS | -0.75 | -18.21 | -10.52 | ||
| EPS Diluted | -1.32 | -37.62 | -19.79 | ||
| Normalized Diluted EPS | -0.75 | -18.21 | -10.52 | ||
| Average Basic Shares Outstanding | 22.70M | 749.80K | 736.90K | ||
| Average Diluted Shares Outstanding | 22.70M | 749.80K | 736.90K | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||